propidium has been researched along with folic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackman, AL; Ormerod, MG; Skelton, LA; Titley, JC | 1 |
| Chmielewski, JA; Low, PS; Reddy, JA; Turk, MJ | 1 |
2 other study(ies) available for propidium and folic acid
| Article | Year |
|---|---|
Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action.
Topics: Animals; Bisbenzimidazole; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Folic Acid; Folic Acid Antagonists; Growth Inhibitors; Humans; Mice; Propidium; Pyridines; Quinazolines; Staining and Labeling; Thymidylate Synthase; Tumor Cells, Cultured | 1998 |
Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.
Topics: Amino Acid Sequence; Cholesterol; Cytarabine; Dextrans; Drug Delivery Systems; Endosomes; Fatty Acids, Monounsaturated; Folic Acid; Genetic Therapy; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Liposomes; Molecular Sequence Data; Peptides; Permeability; Propidium; Quaternary Ammonium Compounds; Transfection; Tumor Cells, Cultured | 2002 |